back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-10-01 16:41 Tx date 2026-09-16 |
$CSCI
COSCIENS Biopharma Inc. |
Spear, David
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 15% Unsecured due September 10, 2027
16 - Acquisition or disposition under a prospectus exemption
|
$
+$200 vol $1,000 each |
$200 | |
| Filed 2026-10-01 16:38 Tx date 2025-05-30 |
$CSCI
COSCIENS Biopharma Inc. |
Spear, David
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 15% Unsecured due September 10, 2027
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-10-01 16:35 Tx date 2026-09-16 |
$CSCI
COSCIENS Biopharma Inc. |
Puccetti, Peter H.
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 15% Unsecured due September 10, 2027
16 - Acquisition or disposition under a prospectus exemption
|
$
+$990 vol $1,000 each |
$990 | |
| Filed 2026-10-01 16:32 Tx date 2025-05-30 |
$CSCI
COSCIENS Biopharma Inc. |
Puccetti, Peter H.
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 15% Unsecured due September 10, 2027
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-10-01 16:27 Tx date 2026-09-10 |
$CSCI
COSCIENS Biopharma Inc. |
Miller, Ronald W.
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 15% Unsecured due September 10, 2027
16 - Acquisition or disposition under a prospectus exemption
|
$
+$50 vol $1,000 each |
$50 | |
| Filed 2026-10-01 16:23 Tx date 2024-06-03 |
$CSCI
COSCIENS Biopharma Inc. |
Miller, Ronald W.
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 15% Unsecured due September 10, 2027
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-10-01 16:20 Tx date 2026-09-10 |
$CSCI
COSCIENS Biopharma Inc. |
La Fratta, Giuliano
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 15% Unsecured due September 10, 2027
16 - Acquisition or disposition under a prospectus exemption
|
$
+$100 vol $1,000 each |
$100 | |
| Filed 2026-10-01 15:30 Tx date 2022-01-24 |
$CSCI
COSCIENS Biopharma Inc. |
La Fratta, Giuliano
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 15% Unsecured due September 10, 2027
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-08-10 19:37 Tx date 2026-08-04 |
$CSCI
COSCIENS Biopharma Inc. |
Regnier, Michel Gerard
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units (RSU)
56 - Grant of rights
|
+11,000 vol |
11,000 | |
| Filed 2026-08-10 19:35 Tx date 2026-08-04 |
$CSCI
COSCIENS Biopharma Inc. |
Regnier, Michel Gerard
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units (RSU)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-08-10 19:13 Tx date 2026-08-04 |
$CSCI
COSCIENS Biopharma Inc. |
Regnier, Michel Gerard
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,180 | ||
| Filed 2026-08-06 14:52 Tx date 2026-08-04 |
$CSCI
COSCIENS Biopharma Inc. |
Giovinazzo, Anthony J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+6,000 vol |
6,000 | |
| Filed 2026-08-06 14:50 Tx date 2025-05-30 |
$CSCI
COSCIENS Biopharma Inc. |
Giovinazzo, Anthony J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-08-04 21:13 Tx date 2026-08-04 |
$CSCI
COSCIENS Biopharma Inc. |
Seager, Robert Andrew
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+6,000 vol |
6,000 | |
| Filed 2026-08-04 21:09 Tx date 2025-05-30 |
$CSCI
COSCIENS Biopharma Inc. |
Seager, Robert Andrew
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-08-04 21:06 Tx date 2026-08-04 |
$CSCI
COSCIENS Biopharma Inc. |
Spear, David
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+6,000 vol |
6,000 | |
| Filed 2026-08-04 21:03 Tx date 2025-05-30 |
$CSCI
COSCIENS Biopharma Inc. |
Spear, David
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-08-04 21:00 Tx date 2026-08-04 |
$CSCI
COSCIENS Biopharma Inc. |
Miller, Ronald W.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+6,000 vol |
11,000 | |
| Filed 2026-08-04 20:56 Tx date 2026-07-03 |
$CSCI
COSCIENS Biopharma Inc. |
Miller, Ronald W.
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-3,304 vol |
1,652 | |
| Filed 2026-08-04 20:53 Tx date 2026-07-03 |
$CSCI
COSCIENS Biopharma Inc. |
Miller, Ronald W.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
37 - Stock split or consolidation
|
-10,000 vol |
5,000 | |
| Filed 2026-08-04 20:49 Tx date 2026-08-04 |
$CSCI
COSCIENS Biopharma Inc. |
Kosciessa, Ulrich
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+6,000 vol |
10,166 | |
| Filed 2026-08-04 20:46 Tx date 2026-07-03 |
$CSCI
COSCIENS Biopharma Inc. |
Kosciessa, Ulrich
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-3,304 vol |
1,652 | |
| Filed 2026-08-04 20:43 Tx date 2026-07-03 |
$CSCI
COSCIENS Biopharma Inc. |
Kosciessa, Ulrich
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
37 - Stock split or consolidation
|
-8,334 vol |
4,166 | |
| Filed 2026-08-04 20:39 Tx date 2026-07-03 |
$CSCI
COSCIENS Biopharma Inc. |
Kosciessa, Ulrich
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,232 vol |
616 | |
| Filed 2026-08-04 20:33 Tx date 2026-08-04 |
$CSCI
COSCIENS Biopharma Inc. |
La Fratta, Giuliano
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSU)
56 - Grant of rights
|
+16,000 vol |
16,000 | |
| Filed 2026-08-04 20:30 Tx date 2022-01-24 |
$CSCI
COSCIENS Biopharma Inc. |
La Fratta, Giuliano
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSU)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-08-04 20:28 Tx date 2026-07-03 |
$CSCI
COSCIENS Biopharma Inc. |
La Fratta, Giuliano
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-334 vol |
166 | |
| Filed 2026-08-04 20:22 Tx date 2026-08-04 |
$CSCI
COSCIENS Biopharma Inc. |
Puccetti, Peter H.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSU)
56 - Grant of rights
|
+37,000 vol |
37,000 | |
| Filed 2026-08-04 20:20 Tx date 2025-05-30 |
$CSCI
COSCIENS Biopharma Inc. |
Puccetti, Peter H.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSU)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-08-04 19:34 Tx date 2026-07-03 |
$CSCI
COSCIENS Biopharma Inc. |
Puccetti, Peter H.
4 - Director of Issuer
Holder: Puccetti Funds Management Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-10,458 vol |
5,229 | |
| Filed 2026-03-06 16:52 Tx date 2026-03-04 |
$CSCI
COSCIENS Biopharma Inc. |
Puccetti, Peter H.
4 - Director of Issuer
Holder: Goodwood Fund (Control or Direction)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-241,570 vol |
0 | |
| Filed 2025-10-23 17:15 Tx date 2025-05-30 |
$CSCI
COSCIENS Biopharma Inc. |
Seager, Robert Andrew
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-10-16 12:24 Tx date 2025-05-30 |
$CSCI
COSCIENS Biopharma Inc. |
Puccetti, Peter H.
4 - Director of Issuer
Holder: Goodwood Fund (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
241,570 | ||
| Filed 2025-10-16 12:20 Tx date 2025-05-30 |
$CSCI
COSCIENS Biopharma Inc. |
Puccetti, Peter H.
4 - Director of Issuer
Holder: Puccetti Funds Management Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
15,687 | ||
| Filed 2025-05-15 13:39 Tx date 2025-05-15 |
$CSCI
COSCIENS Biopharma Inc. |
Biehn, Anna Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+62,927 vol |
62,927 | |
| Filed 2025-05-15 13:37 Tx date 2025-05-05 |
$CSCI
COSCIENS Biopharma Inc. |
Biehn, Anna Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-03-07 11:40 Tx date 2025-01-03 |
$CSCI
COSCIENS Biopharma Inc. (formerly Aeterna Zentaris Inc.) |
Li, William
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-472 vol |
1,416 | |
| Filed 2025-03-07 11:40 Tx date 2025-01-02 |
$CSCI
COSCIENS Biopharma Inc. (formerly Aeterna Zentaris Inc.) |
Li, William
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-1,770 vol |
1,888 | |
| Filed 2025-03-07 11:39 Tx date 2024-11-20 |
$CSCI
COSCIENS Biopharma Inc. (formerly Aeterna Zentaris Inc.) |
Li, William
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-3,540 vol |
3,658 | |
| Filed 2025-03-07 11:33 Tx date 2025-01-03 |
$CSCI
COSCIENS Biopharma Inc. (formerly Aeterna Zentaris Inc.) |
Kosciessa, Ulrich
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-472 vol |
4,956 | |
| Filed 2025-03-07 11:29 Tx date 2025-01-03 |
$CSCI
COSCIENS Biopharma Inc. (formerly Aeterna Zentaris Inc.) |
Gagnon, Gilles
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-1,416 vol |
12,980 | |
| Filed 2025-03-07 11:28 Tx date 2025-01-02 |
$CSCI
COSCIENS Biopharma Inc. (formerly Aeterna Zentaris Inc.) |
Gagnon, Gilles
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-3,540 vol |
14,396 |